Craneware (CRW)
market vs.
industry GROWTH & VALUE
| 12m Forecast Rolling | ||||
| PE Ratio (f) | 15.5 |
|
|
|
| PEG Ratio (f) |
|
|
||
| EPS Growth (f) | % |
|
|
|
| Dividend Yield (f) | % |
|
|
|
| Valuation (ttm) | ||||
| Price to Book Value | 4.10 |
|
|
|
| Price to Tang. Book |
|
|
||
| Price to Free Cashflow |
|
|
||
| Price to Sales |
|
|
||
| EV to EBITDA |
|
|
||
market vs.
industry QUALITY
| Year End 30th Jun | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | TTM | 2013E | 2014E | CAGR / Avg | |
| Revenue | $m | ||||||||||
| Operating Profit | $m | ||||||||||
| Net Profit | $m | ||||||||||
| EPS Reported | $ | ||||||||||
| EPS Normalised | $ | ||||||||||
| EPS Growth | % | ||||||||||
| PE Ratio | x | ||||||||||
| PEG | x | ||||||||||
| Profitability | |||||||||||
| Operating Margin | % | ||||||||||
| ROA | % | ||||||||||
| ROCE | % | ||||||||||
| ROE | % | ||||||||||
| Cashflow | |||||||||||
| Op. Cashflow ps | $ | ||||||||||
| Capex ps | $ | ||||||||||
| Free Cashflow ps | $ | ||||||||||
| Last ex-div: 13th Mar, paid: 12th Apr more... Dividends | |||||||||||
| Dividend ps | $ | ||||||||||
| Dividend Growth | % | ||||||||||
| Dividend Yield | % | ||||||||||
| Dividend Cover | x | ||||||||||
| Balance Sheet | |||||||||||
| Cash etc | $m | ||||||||||
| Working Capital | $m | ||||||||||
| Net Fixed Assets | $m | ||||||||||
| Net Debt | $m | ||||||||||
| Book Value | $m | ||||||||||
| Average Shares | m | ||||||||||
| Book Value ps | $ | +55.9% | |||||||||
FINANCIAL BRIEF: For the six months ended 31 December 2012, Craneware plc revenues increased 7% to $20.1M. Net income increased 20% to $3.3M. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Net income benefited from Deposit Interest Receivable increase of 46% to $54K (income). Dividend per share remained flat at $0.08. more »
| Leverage (ttm) | Total | Ex Intang | |||
| Gross Gearing | % | ||||
| Net Gearing | % | ||||
| Cash / Assets | % | ||||
| Liquidity (ttm) | ||
| Current Ratio | ||
| Quick Ratio | ||
| Interest Cover | ||
| Efficiency (ttm) | ||
| Asset Turnover | ||
| Rec's Turnover | ||
| Stock Turnover | ||
market vs.
industry RECENT HISTORY
| Latest interim period (ended 31st Dec '12) vs. prior year | ||||
| Sales Growth | % |
|
|
|
| EPS Growth | % |
|
|
|
| 3yr Average Annualised | ||||
| Sales Growth | % |
|
|
|
| EPS Growth | % |
|
|
|
| DPS Growth | % |
|
|
|
BROKER CONSENSUS & FORECAST TREND
| Recommendation: | Strong Sell | Sell | Hold | Buy | Strong Buy |
|---|---|---|---|---|---|
| No. of Analysts: | 0 | 0 | 3 | 1 | 1 |
Craneware plc is engaged in the development, licensing and ongoing support of computer software for the United States healthcare industry. The Company’s segments include software licenses, white labeling and professional services. The Company’s products and services include Chargemaster Toolkit, Chargemaster Corporate Toolkit, Chargemaster Toolkit - CAH, Online Reference Toolkit, Bill Analyzer, Interface Scripting Module, Physician Revenue Toolkit, Physician Revenue Toolkit - Corporate and Physician Management Toolkit. Its access management and strategic pricing products also include Pricing Analyzer, Patient Charge Estimator and InSight Medical Necessity. Supply management product includes Pharmacy ChargeLink and Supplies ChargeLink. Audit and revenue recovery products include InSight Audit, InSight Payment Variance Analyzer and InSight Denials.
Directors: Keith Neilson (CEO) 43, Craig Preston (CFO) 41,
No. of Employees: 203 No. of Shareholders: n/a
| Last Annual | June 30th, 2012 |
| Last Interim | December 31st, 2012 |
| Shares in Issue | 26,998,408 |
| Free Float | 18.6m (68.8%) |
| Sector | Healthcare |
| Industry | Healthcare Equipment & Supplies |
| Index | FTSE Aim All Share, FTSE Aim 100, |
| Exchange |
London Stock Exchange (AIM) |
| Eligible for | an ISA? a SIPP? |
| Address | 1 Tanfield, Livingston, EH3 5DA, United Kingdom |
| Web | http://www.craneware.com |
| Phone | +44 131 5503100 |
| Contact | () |
| Registrar | Capita Registrars (Kent) |
| Auditors | PricewaterhouseCoopers LLP |
| 15th Apr | Blocklisting Interim Review |
| 12th Apr | Total Voting Rights |
| 18th Mar | Dividend Currency Election |
| 4th Mar | Total Voting Rights |
| 27th Feb | Director/PDMR Shareholding |
| 26th Feb | Half Yearly Report |
Recent ↓
